Palatin Technologies Voluntarily Transfers Stock Listing to Nasdaq
Express News | Palatin Technologies Inc - to Trade on NYSE American Until May 28, 2026
A. G. P. Maintains Palatin Technologies(PTN.US) With Buy Rating, Cuts Target Price to $47.5
Palatin Technologies Earnings Call: Partnerships, Progress, Risks
10-Q: Quarterly report
Palatin Technologies, Inc. (PTN) Q3 2026 Earnings Call Transcript Summary
Palatin Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q1 EPS Results.
Palatin Is Betting on the Next Generation of Obesity Drugs (NYSE: PTN)
Palatin Techs Q3 EPS $(0.37) Beats $(1.26) Estimate, Sales $3.921M Beat $1.283M Estimate
Palatin Technologies: Runway To Fund Operations Through June 2027 >PTN
Express News | Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Palatin Technologies 3Q Loss/Shr 37c >PTN
Palatin's Case Strengthens as Rhythm's FDA Approval Validates Hypothalamic Obesity Market (PTN)
12 Health Care Stocks Moving In Friday's Pre-Market Session
Palatin Technologies' Rare-Obesity Strategy Sets Up a Catalyst-Rich 2026 for Its MC4R Pipeline (NYSE: PTN)
A. G. P. Maintains Palatin Technologies(PTN.US) With Buy Rating, Maintains Target Price $50
Earnings Call Summary | Palatin Technologies(PTN.US) Q2 2026 Earnings Conference
Palatin Technologies | 10-Q: Q2 2026 Earnings Report
Palatin Technologies GAAP EPS of -$2.86 Misses by $0.51, Revenue of $0.11M Beats by $0.09M
Palatin Techs Q2 EPS $(2.86) Misses $(2.69) Estimate, Sales $116.036K Beat $50.000K Estimate